PharmaCom BioVet, Inc.
OTC: PHMB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Ira Frohman
- Headquarters
- Raleigh, United States
- IPO year
- 1999
- Market cap
- $1.1M
- Website
- https://www.pharmacombiovet.com
Loading PHMB…
Loading profile data…Frequently asked questions about PHMB
What does PharmaCom BioVet, Inc. (PHMB) do?
PharmaCom BioVet, Inc. (PHMB) operates a network of specialized treatment centers across the United States, dedicated to veterinary oncology. The company's core mission involves advancing bone marrow transplantation and various other innovative cancer therapies for companion animals, particularly those diagnosed with lymphoma, other forms of can...
Where does PHMB trade?
PharmaCom BioVet, Inc. (PHMB) trades on the Other OTC.
What sector is PHMB in?
PharmaCom BioVet, Inc. (PHMB) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of PharmaCom BioVet, Inc.?
Ira Frohman is the chief executive officer of PharmaCom BioVet, Inc. (PHMB).
Where is PharmaCom BioVet, Inc. headquartered?
PharmaCom BioVet, Inc. is headquartered in United States.
Does PHMB pay a dividend?
PharmaCom BioVet, Inc. (PHMB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PHMB go public?
PharmaCom BioVet, Inc. (PHMB) completed its initial public offering in 1999.